Co-Diagnostics Inc (CODX)
1.28
+0.08
(+6.67%)
USD |
NASDAQ |
Oct 04, 16:00
1.25
-0.03
(-2.34%)
After-Hours: 20:00
Co-Diagnostics Research and Development Expense (Annual): 22.96M for Dec. 31, 2023
Research and Development Expense (Annual) Chart
Historical Research and Development Expense (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 22.96M |
| December 31, 2022 | 17.44M |
| December 31, 2021 | 14.96M |
| December 31, 2020 | 3.185M |
| December 31, 2019 | 1.371M |
| Date | Value |
|---|---|
| December 31, 2018 | 1.361M |
| December 31, 2017 | 1.003M |
| December 31, 2016 | 0.7315M |
| December 31, 2015 | 0.8069M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
1.371M
Minimum
2019
22.96M
Maximum
2023
11.98M
Average
14.96M
Median
2021
Research and Development Expense (Annual) Benchmarks
| Abbott Laboratories | 2.741B |
| Emergent BioSolutions Inc | 111.40M |
| Tonix Pharmaceuticals Holding Corp | 86.66M |
| SIGA Technologies Inc | -- |
| Chimerix Inc | 68.79M |